|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
08.07.26 - 12:00
|
FDA grants rare paediatric designation to Vanda′s CMT2S therapy (PBR)
|
|
|
The FDA's Office of Orphan Products Development and Office of Pediatric Therapeutics granted this status to the therapy. CMT2S is a rare, inherited neurological condition that progressively causes
The post FDA grants rare paediatric designation to Vanda's CMT2S therapy appeared first on Pharmaceutical Business review....
|
|
|
|
|
|
|
16.06.26 - 04:03
|
SpaceX Erupts In After Hours Trading, Hits $3 Trillion Market Cap, Surpassing Microsoft (ZeroHedge)
|
|
|
SpaceX Erupts In After Hours Trading, Hits $3 Trillion Market Cap, Surpassing Microsoft
Update (9:00pm): just a few minutes after the initial post, the squeeze is accelerating and SPCX hit just shy of $230, or $3 trillion in market cap, surpassing MSFT in value.
And what is even crazier, tomorrow SPCX options start trading, which means one good, solid gamma squeeze could send this stock to $400, surpassing NVDA as the world's biggest company in the process.
Earlier:
After a relatively calm first day of trading, the gamma squeeze crew has finally sniffed out that SpaceX's float makes it a perfect candidate for an OTM-call option driven meltup, and the stock soared ~20% today, adding over $400 billion in market in the regular session.
Commenting on the move, Vanda Track earlier noted that SpaceX topped the leaderboard as the most bought stock by retail investors for a second consecutive session, with net buying potentially set to clear $100mn for the second day in a row.
On a net basis, retail...
|
|
|
|
|
|
|
|